Clal Biotechnology reported ILS3.75M in Trade Debtors for its fiscal quarter ending in December of 2022.





Trade Debtors Change Date
aTyr Pharma USD 1.04M 544K Sep/2025
Clal Biotechnology ILS 3.75M 186K Dec/2022
Compugen USD 2.83M 930K Sep/2025
RedHill Biopharma USD 5.35M 1.78M Jun/2025